Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board withdraws QA rulemaking for §1711 to reassess after AB 1286 changes, delegates drafting to members
Summary
The board voted to withdraw an existing rulemaking package to amend CCR §1711 (quality assurance programs) and to direct staff and designated board members to develop updated regulatory language for committee review, citing AB 1286 and upcoming mandatory medication error reporting.
The California State Board of Pharmacy voted to withdraw the current rulemaking file proposing changes to California Code of Regulations, Title 16, §1711 (quality assurance programs) and to direct further development of the proposal before resubmitting it to the committee process.
Board staff explained that although the board approved proposed language in February 2023, formal rulemaking was delayed until August 2024. Since that time, Assembly…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
